Treatment-Resistant Depression Therapeutics Market Value to reach US$ 4 Billion by 2033; NMDA Drugs to account for 49% of all Treatments: Future Market Insights, Inc. Report
16. Dezember 2022 02:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The global Treatment-Resistant Depression Therapeutics Market is experiencing rapid growth as the prevalence of depression and anxiety disorders...